GBA PRESENTS- the public games

stonedinvestor · Jul 7, 2025 at 11:15 AM

stonedinvestor said:
IMRX Immuneering Corporation- Not going down after 1 month gain of 86%

$3.45-0.14(-3.90%)1:00 PM 07/03/25
More...

Here we go!!!!!

IMRX Immuneering Corporation- //////////

$4.00 +0.55(+15.94%)11:12 AM 07/07/25
NASDAQ |$USD |Realtime

stonedinvestor · Jul 7, 2025 at 11:18 AM

stonedinvestor said:
IMRX Company Profile

Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 that is in Phase 1/2a clinical trial for the treatment of patients with solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.

Immuneering Corp
Zeskind Benjamin J. (PRESIDENT AND CEO) 21,000 @2.39 $50,148 2025-06-18<-----
More...

Clearly there is something much bigger going on than this one smallish insider buy//

Already we ripped 20% on this news...////// TA wise I isolated this name//// I've just been sloppy as fuck lately and I'm not in. i should be.>>>>

Can I buy on a pull in here~~~~ But it's $4.00 I know... // it's just there must be a bigger story here....

stonedinvestor · Jul 7, 2025 at 11:21 AM

stonedinvestor said:
Rezolute ticks higher following disclosure of CFO stock buy
RZLT+5.71%

5,000 @ $4.05 6/24

Company Profile

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. The company’s lead product candidate is ersodetug, a human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It also developing RZ402, an oral plasma kallikrein inhibitor, which is in Phase 2 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.

RZLT Rezolute, Inc.

$4.28 0.25(+6.20%)3:37 PM 06/24/25
More...

Shit/ I'm on fire. One small problem I'm so negative I'm not buying./

RZLT Rezolute, Inc.- Replacement odea???

$5.01 0.19(+3.94%)11:17 AM 07/07/25
NASDAQ |$USD |Realtime

stonedinvestor · Jul 7, 2025 at 11:29 AM

stonedinvestor said:
GM- I am having some sort of shoulder issue. I'm so pissed. someone some ass hole had to tell me about sleeping shoulder or stiff man shoulder and damn if I'm not having issues here day after day and I'm afraid to look it up on the internet because left arm stuff can be heart relayed.. / Damn it. Maybe it's a pinched nerve but with my luck....

I was talking in the bar- & the lack of move for Cogent after they got non dillutive financing is surprising./

Cogent bBosciences secures up to $400 million in non-dilutive financing
NewsWed, Jun. 11

\ Now this: Citi adds 'upside 30-day catalyst watch' on Cogent Biosciences » 05:51 COGT

June 11 COGT-$7.36
+$400 mil
Today's Price- $7.36

GBA Upgrade-->COGT Cogent Biosciences, Inc.
$7.10-0.23(-3.14%)4:00 PM 06/27/25
NASDAQ |$USD |Pre-Market:$7.42+0.32(+4.51%)4:02 AM

More...

WHAT A DAY gba!

I'LL HIT YOU UP AT THE CLOSE.

DarkerthanDarc · Jul 7, 2025 at 3:28 PM

How good is Stoney!

It may or may not be a Correction, but down she's been coming.

DarkerthanDarc · Jul 7, 2025 at 4:32 PM

Stoney, I dedicate this Song to you

Log in or Sign up

GBA PRESENTS- the public games

stonedinvestor

stonedinvestor

stonedinvestor

stonedinvestor

DarkerthanDarc

DarkerthanDarc